STAP revisited

September 2015
Nature;9/24/2015, Vol. 525 Issue 7570, p426
Academic Journal
The article focuses on the scientific controversy of a retracted research paper that was published in "Nature" in 2014 on stimulus-triggered acquisition of pluripotency (STAP), which was claimed as a method to reprogram cells. The author discusses failed research efforts to replicate the findings, articles about STAP research in this present issue of "Nature," recommendations concerning cell line verification, and implications of this incident for future scientific research.


Related Articles

  • Immunobiology of mesenchymal stem cells. Ma, S; Xie, N; Li, W; Yuan, B; Shi, Y; Wang, Y // Cell Death & Differentiation;Feb2014, Vol. 21 Issue 2, p216 

    Mesenchymal stem cells (MSCs) can be isolated from almost all tissues and effectively expanded in vitro. Although their true in situ properties and biological functions remain to be elucidated, these in vitro expanded cells have been shown to possess potential to differentiate into specific cell...

  • Corrigendum: Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Lister, Ryan; Pelizzola, Mattia; Kida, Yasuyuki S.; Hawkins, R. David; Nery, Joseph R.; Hon, Gary; Antosiewicz-Bourget, Jessica; O'Malley, Ronan; Castanon, Rosa; Klugman, Sarit; Downes, Michael; Yu, Ruth; Stewart, Ron; Ren, Bing; Thomson, James A.; Evans, Ronald M.; Ecker, Joseph R. // Nature;10/2/2014, Vol. 514 Issue 7520, p126 

    A correction to the article "Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cell" that was published in the March 03, 2011 issue is presented

  • A robust method to derive functional neural crest cells from human pluripotent stem cells. Kreitzer, Faith R.; Salomonis, Nathan; Sheehan, Alice; Huang, Miller; Park, Jason S.; Spindler, Matthew J.; Lizarraga, Paweena; Weiss, William A.; Po-Lin So; Conklin, Bruce R. // American Journal of Stem Cells;2013, Vol. 2 Issue 2, p119 

    Neural crest (NC) cells contribute to the development of many complex tissues of all three germ layers during embryogenesis, and its abnormal development accounts for several congenital birth defects. Generating NC cells--including specific subpopulations such as cranial, cardiac, and trunk NC...

  • Advances in Induced Pluripotent Stem Cell Technologies. Pal, Rajarshi; Rao, Mahendra; Vemuri, Mohan C.; Verma, Paul; Dinnyes, Andras // Stem Cells International;2012, p1 

    An introduction is presented in which the editor discusses various reports within the issue on topics including the technological advancements in the field of induced pluripotent stem cells (iPSC).

  • Down's Neurons from iPSCs Offer Clues. Breindl, Anette // BioWorld Today;6/3/2013, Vol. 24 Issue 105, Special section p1 

    The article discusses research on induced pluripotent stem cells (iPSCs) with a triplicate set of chromosome 21 in individuals with Down syndrome, published in the May 27, 2013 online issue of the "Proceedings of the National Academy of Sciences."

  • Briefings.  // American Scientist;Nov/Dec2014, Vol. 102 Issue 6, p409 

    The article presents abstracts on science topics in various periodicals including "Systematic Identification of Barriers to Human iPSC Generation" by H. Qin in the July 17, 2014 issue of "Cell," "The Laniakea Supercluster of Galaxies" by R. B. Tully, H. Courtois, Y. Hoffman, and D. Pomarede in...

  • What is the point of large-scale collections of human induced pluripotent stem cells? McKernan, Ruth; Watt, Fiona M // Nature Biotechnology;Oct2013, Vol. 31 Issue 10, p875 

    A letter to the editor is presented related to the study "What is the point of large-scale collections of human induced pluripotent stem cells" by Ruth McKernan and Fiona M Watt in October 2013 issue.

  • Program and Abstracts of the 12th Transgenic Technology Meeting (TT2014).  // Transgenic Research;Oct2014, Vol. 23 Issue 5, p827 

    The article presents abstracts on transgenic technology which include the research in induced pluripotent stem (iPS) cell technology and gene editing, in-vivo validation of cancer genes and drug targets, and embryonic stem cells.

  • 60 SECONDS.  // New Scientist;7/27/2013, Vol. 219 Issue 2927, p7 

    The article presents science news briefs on topics including the response of the World Health Organization to the Middle East coronavirus outbreak, confiscation of elephant tusks by Hong Kong customs agents on a ship from Togo, and clinical trials of induced pluripotent stem cells.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics